Smith & Nephew PLC — Director's Dealing 2022

Sep 14, 2022

National Storage Mechanism | Additional information

RNS Number : 4849Z

Smith & Nephew Plc

14 September 2022

SMITH & NEPHEW PLC

14 September 2022

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Reason for the notification
Initial notification /Amendment	Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name	Smith & Nephew plc
LEI	213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument	Smith & Nephew plc ordinary shares of USD 0.20 each
Identification code	ISIN: GB0009223206
Nature of the transaction	Option granted on 13 September 2022 under the Smith & Nephew ShareSave Plan (2022) at an exercise option price of £8.43 per share.
Date of Transaction	2022 - 09 - 13
Place of Transaction	Outside a trading venue.

Name (Position)	Director / PDMR	Price (£)	Volume of shares under option	Aggregated information	Total Ordinary Share Holding following the transaction *	Total Ordinary Share Holding as a % of the Company's ISC following the transaction *
Phil Cowdy (Chief Business Development & Corporate Affairs Officer)	PDMR	N/A	2,135	N/A Single Transaction	47,133.98046 ordinary shares	0.00537%

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Sarah Carne  

Deputy Company Secretary

Smith & Nephew plc

Tel:  +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFSVARISLIF